VANCOUVER, BC, Oct. 26, 2021 /CNW/ – Mind Cure Health Inc. (CSE: MCUR) (OTCQX: MCURF) (FRA: 6MH) (“MINDCURE” or the “Company”), a leader in advanced proprietary technology and research for psychedelics, today announced its financial results for the three months ended August 31, 2021. All amounts are stated in Canadian dollars unless otherwise indicated. Q1 Fiscal 2022 Business Highlights Released…


Previous articleCybin Announces FDA Investigational New Drug Authorization of Cybin’s Sponsored Feasibility Study Using Kernel Flow Technology
Next articleCybin Announces Launch of EMBARK Psychedelic Facilitator Training Program